Hepatitis C can now be cured in most patients with short courses of oral direct-acting antiviral medicines (DAAs). For an international patient considering treatment in India, the useful question is not only how much treatment costs — it is also whether the infection is still active, whether fibrosis or cirrhosis is present, which antiviral regimen is appropriate, what tests are needed, and whether follow-up can be completed after returning home. This guide explains hepatitis C treatment in India in 2026, expected costs, DAA medicines, required tests, treatment duration, cure testing, cirrhosis follow-up and practical planning for international patients.
Our services are FREE and by using our services your hospital bill does not increase!
Quick answer
Modern hepatitis C treatment is usually based on oral direct-acting antiviral medicines. The World Health Organization states that DAAs can cure more than 95% of people with hepatitis C infection. For many uncomplicated adult patients, treatment lasts 8 or 12 weeks — longer or different treatment may be needed in selected cases, including previous treatment failure or more complex liver disease.
There is no reliable single national private-care price for hepatitis C treatment in India. The total cost depends on the antiviral regimen, diagnostic testing, fibrosis or cirrhosis assessment, specialist consultations, other medical conditions, follow-up testing, and whether treatment is provided through public or private care. Generic DAA medicines can be relatively inexpensive in India, while a complete private international-patient pathway can cost substantially more. Published private-care estimates vary widely, so any online price should be treated as an indicative example rather than a national tariff.
First: confirm that hepatitis C is still active
A positive hepatitis C antibody test does not necessarily mean you currently have active hepatitis C infection. The antibody shows that your immune system has been exposed to the hepatitis C virus at some point — some people clear the infection naturally but remain antibody-positive. Active HCV infection should be confirmed with HCV RNA or another appropriate virological test before antiviral treatment is started.
Before discussing treatment, check whether you have:
- A positive anti-HCV antibody test
- A current HCV RNA / viral-load result
- Recent liver-function tests
- An assessment of liver fibrosis or cirrhosis where appropriate
How much does hepatitis C treatment cost in India?
There is no single standard national price. The total cost can include several different components:
| Cost component | What to clarify |
|---|---|
| Specialist consultation | Initial and follow-up visits |
| HCV RNA testing | Baseline viral load and post-treatment confirmation |
| Liver blood tests | Liver enzymes and other relevant tests |
| Fibrosis assessment | FibroScan, APRI/FIB-4 or other assessment where appropriate |
| Antiviral medicines | Full prescribed DAA course |
| Additional screening | Hepatitis B, HIV, kidney function and other tests |
| Follow-up | SVR12 testing after treatment |
Private-care estimates published online vary considerably and should be treated as planning figures, not official tariffs. The antiviral medicine itself may represent only part of the total treatment cost.
What should a hepatitis C treatment quote include?
A useful private-care quotation may include:
- Hepatology or gastroenterology consultation
- Quantitative HCV RNA test
- Complete blood count
- Liver-function testing
- Kidney-function assessment
- Hepatitis B screening
- HIV testing
- Fibrosis or cirrhosis assessment
- Full prescribed DAA course
- Review for drug interactions
- Post-treatment HCV RNA test
Do not assume that a package labelled "hepatitis C treatment" automatically includes the full medicine course or the final cure test.
How is hepatitis C treated in 2026?
Modern hepatitis C treatment uses direct-acting antiviral medicines. For many treatment-naive adults without cirrhosis, widely used pangenotypic options include glecaprevir/pibrentasvir and sofosbuvir/velpatasvir. The correct regimen depends on factors such as whether cirrhosis is present, whether the patient has received previous HCV treatment, kidney function, other medicines, hepatitis B or HIV coinfection, previous treatment failure, and other relevant medical conditions.
How long does hepatitis C treatment take?
Many uncomplicated adult treatment pathways use 8 or 12 weeks of therapy. For example, current specialist guidance includes glecaprevir/pibrentasvir for 8 weeks in many treatment-naive adults without cirrhosis, and sofosbuvir/velpatasvir for 12 weeks in many treatment-naive adults without cirrhosis. Patients with previous treatment failure, cirrhosis or other complex clinical circumstances may need a different regimen or treatment plan.
What tests are usually needed before treatment?
Pretreatment testing helps confirm active infection and determine whether the patient can follow a simplified treatment pathway. Common tests may include quantitative HCV RNA, complete blood count, liver-function panel, kidney function (eGFR), hepatitis B screening, HIV testing, fibrosis or cirrhosis assessment, pregnancy testing where relevant, and a review of current medicines for possible drug interactions. Patients with cirrhosis may require additional assessment.
Do you need HCV genotype testing?
Not always. Modern pangenotypic antiviral regimens work across multiple hepatitis C genotypes, so genotype testing is no longer required in every uncomplicated treatment pathway. However, genotype may still matter in selected situations — the treating specialist should decide whether genotype testing is necessary.
How is liver fibrosis assessed?
One of the most important questions before treatment is whether significant fibrosis or cirrhosis is present. Assessment may involve FibroScan or another elastography test, APRI or FIB-4 scores calculated from blood tests, imaging, previous biopsy results where available, and clinical assessment. This matters because cirrhosis can affect both treatment planning and long-term follow-up.
How do you know hepatitis C has been cured?
The usual endpoint is SVR12 — sustained virological response 12 weeks or more after treatment ends. This means HCV RNA remains undetectable after treatment. SVR12 is considered a virological cure.
What if you already have cirrhosis?
People with cirrhosis can still often be treated successfully for hepatitis C. However, treatment and follow-up become more specialised. Cirrhosis may affect pretreatment assessment, treatment choice, monitoring and long-term follow-up. Importantly, curing hepatitis C does not completely remove the risks associated with established cirrhosis. Patients with cirrhosis should generally continue surveillance for hepatocellular carcinoma (liver cancer) even after achieving SVR12 — current specialist guidance commonly recommends liver ultrasound every 6 months for patients with cirrhosis.
What if liver disease is already advanced?
Patients with decompensated cirrhosis, liver failure or other severe complications require specialist management. The treatment question may then include both antiviral management of hepatitis C and assessment of advanced liver disease. In some cases, liver transplant evaluation may become a separate consideration — this does not mean that every patient with cirrhosis needs transplantation.
Does everyone need hospital admission?
Usually not. Uncomplicated hepatitis C treatment is generally managed as outpatient care with oral medication. Hospital admission is more likely if the patient has decompensated cirrhosis, liver failure, serious complications, or another medical condition requiring inpatient care. For many international patients, an India visit may mainly involve specialist review, confirmatory testing, liver assessment, treatment planning, and prescription or supply of the appropriate medicines.
Do international patients need to stay in India for the whole treatment?
Often, no. Because treatment may last 8–12 weeks, staying in India for the entire course is not always necessary. Depending on the patient's case, ask whether:
- Medical records can be reviewed before arrival
- Pretreatment blood tests can be completed at home
- The full medicine course can be arranged after assessment
- Routine monitoring can be done locally
- SVR12 testing can be performed after returning home
- Follow-up results can be reviewed remotely
Medical visa for hepatitis C treatment in India
If the main reason for travel is medical treatment, check which Medical Visa or e-Medical Visa route applies to your passport — India's visa rules differ by nationality. Before booking non-refundable travel, confirm which visa category applies, whether hospital documentation is required, whether an accompanying person needs a Medical Attendant Visa, and the validity and entry conditions shown on the issued authorization.
How to choose a hepatitis C doctor or hospital in India
For uncomplicated hepatitis C treatment, the largest hospital is not automatically the most appropriate option. A hepatologist or gastroenterologist experienced in viral hepatitis and liver disease is usually more relevant than a general hospital ranking. Before deciding, ask:
- Has active infection been confirmed with HCV RNA?
- Has fibrosis or cirrhosis been assessed?
- Which DAA regimen is recommended and why?
- How long will treatment last?
- Have my current medicines been checked for interactions?
- What exactly is included in the treatment price?
- Where and when will SVR12 be checked?
- If cirrhosis is present, what long-term surveillance is recommended?
Can hepatitis C treatment be free in India?
India operates the National Viral Hepatitis Control Programme, which provides hepatitis screening, diagnosis and treatment through designated public-health services. However, an international patient should not assume eligibility for free treatment — access can depend on programme rules, facility availability and patient status.
Hepatitis C treatment checklist for international patients
Before starting treatment, make sure you know:
- Whether HCV RNA confirms active infection
- Whether fibrosis or cirrhosis is present
- The exact antiviral regimen prescribed
- Planned treatment duration
- Whether your medicines have been checked for interactions
- Whether the quote includes the full DAA course
- Which diagnostic tests are included
- Where SVR12 will be performed
- Whether you need to stay in India during treatment
- What follow-up will be needed after cure
Frequently asked questions
How much does hepatitis C treatment cost in India?
There is no reliable single national private-care price. The total cost depends on the DAA regimen, diagnostic testing, fibrosis assessment, specialist fees and follow-up. Generic hepatitis C medicines can be relatively inexpensive in India, while a complete private international-patient pathway can cost considerably more. Published online estimates should be treated as indicative examples, not official tariffs.
Can hepatitis C be cured?
In most patients, yes. WHO states that modern direct-acting antivirals cure more than 95% of people with hepatitis C infection.
Does a positive hepatitis C antibody test mean I need treatment?
Not necessarily. A positive antibody test shows previous exposure to hepatitis C. HCV RNA or another appropriate virological test is needed to determine whether active infection is present.
How long does hepatitis C treatment take?
Many uncomplicated adult treatment pathways use 8 or 12 weeks of DAA therapy. Some patients may need a different treatment course.
Do I need genotype testing?
Not always. Pangenotypic DAA regimens have reduced the need for genotype testing in uncomplicated cases, although it can still be relevant in selected patients.
How is hepatitis C cure confirmed?
A quantitative HCV RNA test is generally performed 12 weeks or more after treatment ends. If the virus remains undetectable, this is called SVR12 and is considered virological cure.
Does curing hepatitis C cure cirrhosis?
Not necessarily. Successful treatment reduces future liver-related risks, but established cirrhosis can still require long-term monitoring. Patients with cirrhosis may continue to need liver cancer surveillance, commonly with ultrasound every 6 months, even after hepatitis C has been cured.
Do I need to stay in hospital?
Usually not for uncomplicated hepatitis C. Modern DAA therapy is generally outpatient treatment with oral medicines.
Can I finish treatment after returning home?
Often, yes, if the treating specialist considers this appropriate. Monitoring and SVR12 testing may be performed in the patient's home country and shared with the Indian medical team.
Sources and medical references
Not sure where to start?
Start with your HCV RNA result, recent liver tests and any previous hepatitis C treatment records. With your consent, Medical Help India will connect you with relevant healthcare providers who can help coordinate suitable liver specialist and hospital options, appointments, treatment and cost information, and practical planning. The treating doctor remains responsible for diagnosis, prescribing and treatment decisions.
Our service is free for patients and does not increase the hospital bill.